References
- KestonASBallRPFrantzVKPalmerWWStorage of radioactive iodine in a metastasis from thyroid carcinomaScience194295246636236317745299
- SeidlinSMRossmanIOshryESiegelERadioiodine therapy of metastases from carcinoma of the thyroid; a 6-year progress reportJ Clin Endocrinol Metab19499111122113715395978
- TazebayUHWapnirILLevyOThe mammary gland iodide transporter is expressed during lactation and in breast cancerNat Med20006887187810932223
- RenierCVogelHOfforOYaoCWapnirIBreast cancer brain metastases express the sodium iodide symporterJ Neurooncol201096333133619618116
- RyanJCurranCEHennessyEThe sodium iodide symporter (NIS) and potential regulators in normal, benign and malignant human breast tissuePLoS One201161e1602321283523
- UpadhyayGSinghRAgarwalGFunctional expression of sodium iodide symporter (NIS) in human breast cancer tissueBreast Cancer Res Treat200377215716512602914
- WapnirILGorisMYuddAThe Na+/I- symporter mediates iodide uptake in breast cancer metastases and can be selectively down-regulated in the thyroidClin Cancer Res200410134294430215240514
- WapnirILvan de RijnMNowelsKImmunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sectionsJ Clin Endocrinol Metab20038841880188812679487
- ChatterjeeSMalhotraRVargheseFQuantitative immunohistochemical analysis reveals association between sodium iodide symporter and estrogen receptor expression in breast cancerPLoS One201381e5405523342072
- MoonDHLeeSJParkKYCorrelation between 99mTc-pertechnetate uptakes and expressions of human sodium iodide symporter gene in breast tumor tissuesNucl Med Biol200128782983411578905
- KogaiTTakiKBrentGAEnhancement of sodium/iodide symporter expression in thyroid and breast cancerEndocr Relat Cancer200613379782616954431
- LiuZXingMInduction of sodium/iodide symporter (NIS) expression and radioiodine uptake in non-thyroid cancer cellsPLoS One201272e3172922359623
- KogaiTSchultzJJJohnsonLSHuangMBrentGARetinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell lineProc Natl Acad Sci U S A200097158519852410890895
- BiaglowJEClarkEPEppERMorse-GuadioMVarnesMEMitchellJBNonprotein thiols and the radiation response of A549 human lung carcinoma cellsInt J Radiat Biol Relat Stud Phys Chem Med19834454894956605951
- MitchellJBRussoAThe role of glutathione in radiation and drug induced cytotoxicityBr J Cancer19878Suppl96104
- BlackburnRVSpitzDRLiuXMetabolic oxidative stress activates signal transduction and gene expression during glucose deprivation in human tumor cellsFree Radic Biol Med1999263–44194309895234
- ParniakMKalantNIncorporation of glucose into glycogen in primary cultures of rat hepatocytesCan J Biochem Cell Biol19856353333403893656
- SpitzDRSimJERidnourLAGaloforoSSLeeYJGlucose deprivation-induced oxidative stress in human tumor cells. A fundamental defect in metabolism?Ann N Y Acad Sci200089934936210863552
- LinXZhangFBradburyCM2-Deoxy-D-glucose-induced cytotoxicity and radiosensitization in tumor cells is mediated via disruptions in thiol metabolismCancer Res200363123413341712810678
- SongCWLeeHDingsRPMetformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cellsSci Rep2012236222500211
- GrothACOlivaresECThyagarajanBCalosMPA phage integrase directs efficient site-specific integration in human cellsProc Natl Acad Sci U S A200097115995600010801973
- FrankenNARodermondHMStapJHavemanJvan BreeCClonogenic assay of cells in vitroNat Protoc2006152315231917406473
- Ben SahraILaurentKLoubatAThe antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 levelOncogene200827253576358618212742
- BuzzaiMJonesRGAmaravadiRKSystemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growthCancer Res200767146745675217638885
- DowlingRJGoodwinPJStambolicVUnderstanding the benefit of metformin use in cancer treatmentBMC Med201193321470407
- ZakikhaniMDowlingRFantusIGSonenbergNPollakMMetformin is an AMP kinase-dependent growth inhibitor for breast cancer cellsCancer Res20066621102691027317062558
- HirschHAIliopoulosDTsichlisPNStruhlKMetformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remissionCancer Res200969197507751119752085
- DwarkanathBSZolzerFChandanaSHeterogeneity in 2-deoxy-D-glucose-induced modifications in energetics and radiation responses of human tumor cell linesInt J Radiat Oncol Biol Phys20015041051106111429233
- CazzanigaMBonanniBGuerrieri-GonzagaADecensiAIs it time to test metformin in breast cancer clinical trials?Cancer Epidemiol Biomarkers Prev200918370170519240238
- MohantiBKRathGKAnanthaNImproving cancer radiotherapy with 2-deoxy-D-glucose: phase I/II clinical trials on human cerebral gliomasInt J Radiat Oncol Biol Phys19963511031118641905
- Ben SahraITantiJFBostFThe combination of metformin and 2-deoxyglucose inhibits autophagy and induces AMPK-dependent apoptosis in prostate cancer cellsAutophagy20106567067120559023